Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13451
Peer-review started: September 26, 2022
First decision: October 28, 2022
Revised: November 10, 2022
Accepted: December 5, 2022
Article in press: December 5, 2022
Published online: December 26, 2022
Processing time: 91 Days and 4 Hours
The clinical course of acute myocarditis ranges from the occurrence of a few symptoms to the development of fatal fulminant myocarditis. Specifically, fulminant myocarditis causes clinical deterioration very rapidly and aggressively. The long-term prognosis of myocarditis is varied, and it fully recovers without leaving any special complications. However, even after recovery, heart failure may occur and eventually progress to dilated cardiomyopathy (DCM), which causes serious left ventricular dysfunction. In the case of follow-up observation, no clear guidelines have been established.
We report the case of a 21-year-old woman who presented with dyspnea. She became hemodynamically unstable and showed sustained fatal arrhythmias with decreased heart function. She was clinically diagnosed with fulminant myocarditis based on her echocardiogram and cardiac magnetic resonance results. After 2 d, she was readmitted to the emergency department under cardiopulmonary resuscitation and received mechanical ventilation and extracorporeal membrane oxygenation. An implantable cardioverter defibrillator was inserted for secondary prevention. She recovered and was discharged. Prior to being hospitalized for sudden cardiac function decline and arrhythmia, she had been well for 7 years without any complications. She was finally diagnosed with dilated cardiomyopathy.
DCM may develop unexpectedly in patients who have been cured of acute fulminant myocarditis and have been stable with a long period of remission. Therefore, they should be carefully and regularly observed clinically throughout long-term follow-up.
Core Tip: While dilated cardiomyopathy (DCM) has been well-known as a complication in patients who develop fulminant myocarditis, it is still unclear when DCM might occur. We report the case of a young woman who developed DCM after 7 years of remission without any special complications after recovering from viral myocarditis. No case of DCM development has been reported after such a long latent period of normal cardiac function after a full recovery from viral fulminant myocarditis. We, therefore, suggest that clinicians be aware that DCM can develop unexpectedly and that careful clinical monitoring is required regularly.